AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

RNXT · NASDAQ · Biotechnology

RenovoRx (RNXT)

Develops targeted intra-arterial chemotherapy and commercializes the RenovoCath delivery device.

$2.60

Pre-market+0.09 (+3.58%)

At close$2.51(+18.96%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions29 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail	≈ 8.37%	3.78M shares
Insiders7 holders · as of Jun 24, 2026	13.98%	6.31M shares
Otherremainder	≈ 77.65%	35.05M shares

45.13M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Orin HirschmanInsider	9.82%	4.43M	13Gfiled Apr 27, 2026 ↗
Bleichroeder LPInstitution	3.69%	1.67M	13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution	3.20%	1.44M	13Fas of Jun 30, 2026
Ramtin AgahInsiderdirector, officer: Chief Medical Officer	1.77%	798,460	Form 4filed Jan 22, 2026 ↗
Shaun BagaiInsiderdirector, officer: Chief Executive Officer	1.45%	653,397	Form 4filed Mar 24, 2026 ↗
Geode Capital Management, LLCInstitution	0.94%	424,148	13Fas of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution	0.53%	240,330	13Fas of Jun 30, 2026
Mark VollInsiderofficer: Chief Financial Officer	0.53%	239,580	Form 4filed May 21, 2026 ↗
Una S. RyanInsiderdirector	0.22%	97,165	Form 4filed Jun 24, 2026 ↗
Laurence MartonInsiderdirector	0.17%	75,884	Form 4filed Mar 24, 2026 ↗
Ron KocakInsiderofficer: VP Controller and PAO	0.03%	12,595	Form 4filed Apr 10, 2025 ↗
Mercer Global Advisors Inc /AdvInstitution	0.00%	1,100	13Fas of Jun 30, 2026
Boston Scientific CorporationStrategic	—8.00% of class, as filed	—	13Gfiled Feb 10, 2022 ↗
Bank of the West¹Strategic10 percent owner	2.16%	975,000	Form 4filed Apr 14, 2022 ↗
K. Angela Macfarlane²Insiderdirector	0.09%	40,983	Form 4filed Jan 30, 2024 ↗
Robert J. Spiegel²Insiderdirector	0.09%	40,983	Form 4filed Jan 30, 2024 ↗
Paul Manners³Insiderofficer: Chief Financial Officer	0.05%	23,333	Form 4filed Aug 25, 2021 ↗
Kamran Najmabadi³Insider10 percent owner	0.02%	10,000	Form 4filed Aug 25, 2021 ↗
Angela Nelms⁴Insiderofficer: Chief Operating Officer	0.00%	1,100	Form 4filed Oct 4, 2023 ↗

Last filed Apr 14, 2022; leaving the company requires no filing. Not in the bar.
Last filed Jan 30, 2024; leaving the company requires no filing. Not in the bar.
Last filed Aug 25, 2021; leaving the company requires no filing. Not in the bar.
Last filed Oct 4, 2023; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

29 holders · 3.78M shares · 4 new positions · 12 increased · 6 reduced · 6 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Bleichroeder LP	1.67M	3.69%	0	Aug 13, 2026
Vanguard Capital Management LLC	1.44M	3.20%	−3.4K	Aug 13, 2026
Geode Capital Management, LLC	424.1K	0.94%	+42.4K	Aug 12, 2026
Vanguard Fiduciary Trust Co	240.3K	0.53%	+82.4K	Aug 13, 2026
Mercer Global Advisors Inc /Adv	1.1K	0.00%	+1.1Knew	Aug 11, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Orin Hirschman	9.80%	4.43M	13G	Apr 27, 2026 ↗
Hirschman Orin	9.50%	3.47M	13G	May 8, 2025 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
May 19, 2026	Mark Vollofficer: Chief Financial Officer	Purchase	25,000	$0.7876	142,380
Mar 20, 2026	Mark Vollofficer: Chief Financial Officer	Purchase · 2 lots	145,800	$1.93	145,800
Mar 20, 2026	Shaun Bagaidirector, officer: Chief Executive Officer	Purchase · 2 lots	36,450	$1.93	325,507
Mar 20, 2026	Laurence Martondirector	Purchase · 2 lots	14,580	$1.93	14,580
Jan 21, 2026	Ramtin Agahdirector, officer: Chief Medical Officer	Purchase	10,000	$0.9975	798,460
Dec 31, 2025	Ramtin Agahdirector, officer: Chief Medical Officer	Purchase	9,795	$0.8600	788,460
Dec 30, 2025	Ramtin Agahdirector, officer: Chief Medical Officer	Purchase	205	$0.8260	778,665
Dec 18, 2025	Shaun Bagaidirector, officer: Chief Executive Officer	Purchase	5,000	$0.9013	340,040
Dec 17, 2025	Shaun Bagaidirector, officer: Chief Executive Officer	Purchase	5,000	$0.8524	335,040
Dec 16, 2025	Ramtin Agahdirector, officer: Chief Medical Officer	Purchase	12,000	$0.8500	778,460

CongressHouse and Senate disclosures

Not reported.